Seabirds Imitates Like Canaries In A Coal Mine, Emergency Message From Ocean

Like all birds Seabirds also migrate from one place to another through Earth’s marinescapes in order to find food and reproduce. This reveals them to swap in ocean conditions, climate, and food webs.

“Just as caged canaries once warned coal miners about the risk of carbon monoxide poisoning, free-flying seabirds are now warning humanity of the deteriorating health of our oceans.”

Seabirds travel long distances all over the planet. A typical procreate named black shearwaters in New Zealand, migrates every year to the fecund waters of the Northeast Pacific. Whereas Arctic terns migrates between the Arctic and Antarctica.

By the use of satellite procured datas scientists frequently regulating the oceans conditions such as how ocean surfaces are warming or how ocean food webs are replacing.

Throughout the journey of ocean birds they eats fish and plankton. While doing so , it consumes signals about ocean conditions, together with the effects of pollution, marine heat waves, ocean warming, and other ecological changes.

The productiveness (no:of chicks reproduced per year) of seabird nurture hinges on the availability of food amenity. By this process seabirds are maintaining their marine ecosystems. And also they can apprise us which regions of the oceans are aerobicized enough to propup their reproduction and which region may be in vexations.

“In some cases, seabirds inform us directly about the great difficulties in the oceans. This was the case in 2015-16, when about a million emaciated common murres, many of them on beaches from California to Alaska. Seabirds experienced severe food shortages caused by an acute marine heat wave.“

“In other cases, the health of seabirds may suggest a long-term and more subtle alteration of ocean ecosystems, and we are left to decipher these messages.“

Study Conducting By ICMR To Scrutinize The Virtue Of Covishield And Covaxin In Preventing Covid-19

Since the innovation of AstraZeneca’s Covishield and Bharat Biotech’s Covaxin in the country, the Indian Council of Medical Research (ICMR) will appraise a  study  from next week to scrutinize the potency of these vaccines in preclude the concatenation of  Covid into a critical form.

As reported by senior scientist Dr Tarun Bhatnagar  at ICMR’s National Institute of Epidemiology (NIE) in Chennai revealed that, approaching 4,000 folks  the people exceeds  the age of 45 years who have taken each of  two doses either of  two vaccines will be criticized.

“As a part of the study we will take people who are COVID-19 positive and hospitalised and compare their vaccination status with those who have tested Covid negative,” Bhatnagar told PTI. The aim is to assess how effective vaccination is in preventing progression of the disease into a severe form,” he said.

Up to the present time around 20 crore  amassed vaccine doses has disbursed  in the country  so far.

The Central Government is impelling people to get vaccinated by perpetuating that the vaccine will not fortify one from dwindle the corona virus infection but by inoculating the two doses of the vaccine it will prohibits the concatenation to a extreme stage and will bring down the fatality rate.

The central authorities has been pressurizing about the necessity of wearing a face mask and adhesion to covid protocols.

At present India is using 3 vaccines against this pandemic, which includes Covishield, Covaxin , and Sputnik. Among this covishield is  manufactured by the Pune-based Serum Institute and Covaxin of Bharat Biotech in Hyderabad. Finally the Russian Sputnik V needs the approval from Drug Controller General of India (DCGI) for Emergency Use Authorization and is hardly used in private hospitals so far.

This first of its kind study is expected to be undertaken from next week, said Dr Tarun Bhatnagar, senior ICMR scientist.

COVID 19: Nitrogen Plants Converts Into Oxygen Generators By IIT Bombay

We all know that our world is facing a life threatening disease called COVID 19 which is also known as Corona virus a global pandemic.

This virus cause severe acute respiratory syndrome(SARS) which leads to death. More than million cases has been confirmed. Due to this SARS  oxygen availability is dropping in some countries. In-order to overcome this threatening issue Indian Institute of Technology – Bombay (IIT –B) has come to light with a creative idea of converting Nitrogen generators to Oxygen generators.

This process of conversion is reckoned on a simple technology of permuting a pressure swing adsorption (PSA) nitrogen unit into a PSA oxygen unit.

After the primary tests they promised that the production of oxygen can be attained at 3.5atmospheric pressure with the sterility of 93% to 96%.

This pure gaseous form of oxygen can be used for COVID 19 related requirements. During this COVID 19 pandemic the scarcity of medical oxygen becomes a great threat for our country. The patients are grappling to get proper treatment due to lack of oxygen availability.

The pilot project was a joint effort between IIT Bombay, Tata Consultancy  Engineers  and  Spantech Engineers Mumbai. On the study about this oxygen crisis these three firms signed a Memo of Understanding to conclude about this project.

However to perform this  conversion of existing nitrogen plants  to oxygen convertors it will almost take four days which is less time compared to setup a new oxygen plant.

“It [conversion of nitrogen unit into an oxygen unit] has been done by fine-tuning the existing nitrogen plant set-up and changing the molecular sieves from carbon to zeolite,” the statement said quoting prof. Milind Atrey, dean (R&D), IITB, who led the project.

On 29th may 2021, IIT –B was declared about the proposal of converting nitrogen plants to oxygen generators. This solution of oxygen scarcity will helps to provide oxygen to the hospitals.

Truecaller Launched COVID Hospital Directory To Help Users

For Indian people seeking assistance during the pandemic, Truecaller has introduced a new COVID Hospital Directory. The directory is based on official government databases and contains the phone numbers and addresses of designated COVID-19 hospitals from various states throughout the world.

Truecaller claims that the data for the new feature came from official government databases. The directory is integrated into the software, and users can easily access it from the menu or dialer.

“We wanted to quickly introduce a simple directory of important numbers for Covid-related services. We have started with this hospital list and we’re working to add more verified sources soon,“ said Rishit Jhunjhunwala, MD India, Truecaller.

These hospitals are located in the United States and are based on official government databases. There is a search button that will help you find the details you need quickly. It is necessary to remember that this does not guarantee the availability of hospital beds.

The company also promises to update the database on a daily basis to ensure that as many hospital phone numbers as possible are available throughout India. On Android devices, users will need to update the app from the Google Play Store to see the functionality. As of now, the feature is only available on Android smartphones.

Twitter, for example, is releasing an advanced search feature that will assist users in finding specific information. Using the advanced search function, they can narrow down their search to a specific location, hashtags, and the date the tweet was released. You can learn more about how to use the function by clicking here.

COVID-19 Vaccine Registration to Go Live in India for People Aged Above 18 Years From Today

COVID-19 vaccine registration in India for people aged between 18 and 44 years will go live from 4pm Wednesday, April 28.

This will be the third step of India’s vaccination campaign, which will broaden the current vaccination requirements to include people aged 45 and up. COVID-19 vaccination registration is required, and qualified individuals must have a valid Indian identification evidence, such as an Aadhaar card or a PAN card. India recently registered over 350,000 cases in a single day, the world’s highest total.

The government has made it mandatory for people aged 18 to 44 to register on the CoWIN portal and schedule a coronavirus vaccination appointment, stating that walk-ins would not be permitted at first to prevent “chaos” at immunisation centers until the inoculation campaign ramps up significantly.

Covaxin, produced by Hyderabad-based Bharat Biotech, and Covishield, developed by Oxford-AstraZeneca and manufactured by the Serum Institute of India, are the two COVID-19 vaccines currently being used in the vaccination campaign (SII).

Covishield, manufactured by the Serum Institute of India, will cost states Rs 400 per dose and private hospitals Rs 600 per dose, while Bharat Biotech’s Covaxi will cost states Rs 600 per dose and private hospitals Rs 1,200 per dose.

But don’t get your hopes up too high; while India has vaccinated a large number of people, we still have an absurdly large population, and the new push would simply increase the number of people who will be vaccinated.